Real-life performance of a galactomannoprotein-detecting lateral flow immunoassay (AspLFD) in lower respiratory tract and serum specimens for screening pulmonary aspergillosis.

Published 05/22/2026

Research record: Real-life performance of a galactomannoprotein-detecting lateral flow immunoassay (AspLFD) in lower respiratory tract and serum specimens for screening pulmonary aspergillosis.

Published in Diagn Microbiol Infect Dis; first publication date 2026-05-22. PMID 42208190.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-05-22

Updated

2026-10-20

Disclaimer

professional use

References